ST. LOUIS--(BUSINESS WIRE)--D2 Consulting, a leading life sciences consulting firm offering strategic and tactical commercialization services to pharmaceutical, biotechnology, medical device and digital health manufacturers, announces that retired Air Force Colonel David W. Bobb, attorney and former chief of Pharmacy Operations, Defense Health Agency, has been appointed vice president, Department of Defense (DoD) Market Access. With proven experience in both the civilian and federal healthcare management sectors, Bobb brings valuable insight and expertise into the federal markets, including the Department of Veteran’s Affairs (VA).
Bobb welcomes the opportunity to join the D2 team and share his expertise with pharmacy beneficiaries, stating, “D2 is results-driven, with a deep understanding of the federal healthcare space, and uniquely positioned to not only help industry stakeholders understand the nuances and complexities of the federal government procurement process, but also build long-lasting, beneficial relationships. I look forward to assisting D2 clients in building a better healthcare benefit for our nation’s active duty members, families, veterans and retirees who have given so much in service to their country.”
Throughout his career, Bobb has provided sound legal advice to federal pharmacists in respect to changing Food and Drug Administration policies, Drug Enforcement Administration laws, and federal and state legislative initiatives. He has worked with Congressional delegations, drafted Congressional testimony for superiors, and provided briefings to both Senate and House Armed Services Committee senior staff. He has successfully managed and executed multi-billion-dollar budgets, integrated and consolidated diverse healthcare systems, and provided leadership and strategic direction for the transition of pharmacy services in alignment with Defense Health Agency priorities. A well-known speaker within the federal sector, he has provided accredited pharmacy law presentations and updates at numerous conferences for over 25 years.
Cheryl Nagowski, vice president, Federal Markets, D2 Consulting, says, “We are incredibly honored to have been chosen as Dave’s landing ground for his post-DoD career. He complements our team’s ability to provide perspective from both sides of the table, public and private. Dave provides the latest in DoD actionable insights not found elsewhere in the market, enhancing our ability to provide warfighters and veterans with access to the therapies they need most.”
Bobb has been an integral member of several Boards of Directors, including the American Society for Pharmacy Law, Department of Defense Pharmacy Advisory Board, and the San Antonio Uniformed Services Health Education Consortium. He has worked closely with federal pharmacy partners, such as Veterans Affairs and the Public Health Service, and has authored over 20 publications for federal pharmacists and technicians.
Dean Erhardt, CEO, D2 Consulting, says, ”David’s leadership advisory role to the DoD/TRICARE transformation and his broad, high-profile experience enhance our capabilities to successfully guide clients seeking access enhancement in this exciting and challenging market segment.”
About D2 Consulting
D2 Consulting is a leading provider of commercialization services to the healthcare and life sciences industries, D2 works across all stakeholders including manufacturers, payers and channel participants to execute strategic business initiatives that ensure successful launch, distribution and reimbursement to maximize market impact and support an ongoing leadership position in the marketplace. Visit http://d2rx.com/.